Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATx201 in Impetigo
NCT03429595Phase 2Completed
- Sponsor
- UNION therapeutics
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niclosamide in impetigo, sponsored by UNION therapeutics. Started Feb 2018; status: completed.
02
Drugs
niclosamide
03
Conditions
impetigo
Beyond the preview
Go deeper on NCT03429595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429595.